Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

Abstract

The authors would like to thank the support of the National Multiple Sclerosis Society (USA) and the Multiple Sclerosis Society of Great Britain and Northern Ireland